Trial Profile
A Multi-Part, Randomized, Single-Blind, Placebo-Controlled, Single Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Intravenous TRV130A in Healthy Adult Males.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 12 Feb 2018
Price :
$35
*
At a glance
- Drugs Oliceridine (Primary)
- Indications Pain
- Focus Adverse reactions; Pharmacokinetics
- 07 Feb 2018 Results of pooled data from six phase 1 and phase 2 trial assessing population pharmacokinetic/pharmacodynamic (PK/PD) model of the PK and PD of oliceridine, were published in the Journal of Clinical Pharmacology.
- 14 Oct 2013 Results published in the Journal of Clinical Pharmacology.
- 01 Jul 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.